1-6 of 6
Aparna Rao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 245: Glutamine fuels the TCA cycle in VHL and FH mutant renal cell carcinoma

Akash K. Kaushik, Cissy Yong, Mukundan Ragavan, Christina Stevens, Layton Woolford, Aparna Rao, Brandon Faubert, Panayotis Pachnis, Lauren Zacharias, Hieu Vu, Matthew Merritt, James Brugarolas, Ralph J. DeBerardinis
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 245.
https://doi.org/10.1158/1538-7445.AM2020-245
Published: 15 August 2020
View article titled, Abstract 245: Glutamine fuels the TCA cycle in <em>VHL</em> and <em>FH</em> mutant renal cell carcinoma
Journal Articles

Abstract 5574: Retinoic acid as a therapeutic adjuvant in low-grade gliomas

Aparna Rao, Xiaoran Zhang, Jason Kim, Alexander Pomerantz, Youngmi Kim, Eric Holland, Nduka Amankulor
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 5574.
https://doi.org/10.1158/1538-7445.AM2017-5574
Published: 01 July 2017
View article titled, Abstract 5574: Retinoic acid as a therapeutic adjuvant in low-grade gliomas
Journal Articles

Abstract 3235: IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligands

Aparna Rao, Xiaoran Zhang, Christopher Deibert, Paola Sette, Tim Chan, Paola Grandi, Nduka Amankulor
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3235.
https://doi.org/10.1158/1538-7445.AM2016-3235
Published: 15 July 2016
View article titled, Abstract 3235: IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligands
Journal Articles

Combination Therapy with HSP90 Inhibitor 17-DMAG Reconditions the Tumor Microenvironment to Improve Recruitment of Therapeutic T cells

Aparna Rao, Jennifer L. Taylor, Nina Chi-Sabins, Mayumi Kawabe, William E. Gooding, Walter J. Storkus
Journal: Cancer Research
Cancer Res (2012) 72 (13): 3196–3206.
https://doi.org/10.1158/0008-5472.CAN-12-0538
Published: 01 July 2012
View article titled, Combination Therapy with HSP90 Inhibitor 17-DMAG Reconditions the Tumor Microenvironment to Improve Recruitment of Therapeutic T cells
Open the PDF for Combination Therapy with HSP90 Inhibitor 17-DMAG Reconditions the Tumor Microenvironment to Improve Recruitment of Therapeutic T cells in another window
Includes: Supplementary data
Journal Articles

Abstract 4399: Immunostimulatory effects of HSP90 inhibition: Insights from combinational immunotherapies targeting EphA2

Aparna Rao, Mayumi Kawabe, Walter J. Storkus
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 4399.
https://doi.org/10.1158/1538-7445.AM2012-4399
Published: 15 April 2012
View article titled, Abstract 4399: Immunostimulatory effects of HSP90 inhibition: Insights from combinational immunotherapies targeting EphA2
Journal Articles

Abstract 1805: Integration of 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG) in combinational immunotherapy targeting tumor antigen EphA2

Aparna Rao, Mayumi Kawabe, Walter J. Storkus
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1805.
https://doi.org/10.1158/1538-7445.AM2011-1805
Published: 15 April 2011
View article titled, Abstract 1805: Integration of 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG) in combinational immunotherapy targeting tumor antigen EphA2